The GOOD Company Project visits Cytori Therapeutics, a company working on the next generation of health care tools.
Cytori Therapeutics was among our first GOOD Company finalists, and for good reason: They've developed an innovative product that could make stem cell treatments a part of every physician's tool kit. Now they've deployed their flagship technology, the Cellution System, toward reconstructive surgery for women who required surgery to treat breast cancer. But Cytori's main goal has always been to attack heart disease, the number one cause of death in this country. Check out the video to learn more about the science behind Cytori, how it can improve the economy and why it's not available in the United States—yet.